Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75). by Prasanna Herath (20714794)

Subjects:

Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx by Emmama Jamil (22005635)

Test soil parameters. by Yonggang Huang (223155)

“…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”

Influence of UHMWPE length on swelling pressure. by Yonggang Huang (223155)

“…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”

UHMWPF parameters. by Yonggang Huang (223155)

“…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”

Influence of UHMWPE content on swelling pressure. by Yonggang Huang (223155)

“…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”

Soil partice-size distribution. by Yonggang Huang (223155)

“…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”

<i>CTSZ</i> SNPs significantly associated with TB severity in Ugandan household contact study cohorts, sorted by ascending <i>p</i>-value. by Rachel K. Meade (22216529)

Vasopressor titration regimen in the balanced multimodal group. by Žiga Kalamar (22145810)

Subjects:

The schedule of enrollment, interventions and assessments. by Žiga Kalamar (22145810)

Subjects:

GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

Subjects:

Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

Subjects:

Descriptive statistics (means) for full sample and by lockdown status. by Drew B. Cameron (10687420)

Subjects:

Study sites and number of participants enrolled in the KAP and OOP surveys. by Drew B. Cameron (10687420)

Subjects:

Average cost per visit for HIV and HTN care (absolute vs. relative contributions). by Drew B. Cameron (10687420)

Subjects:

GLM models for predictors of monthly HTN care costs. by Drew B. Cameron (10687420)

Subjects:

Median monthly care costs, projected visits, and hospitalization costs. by Drew B. Cameron (10687420)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects: